Cancer stem cells (CSCs),also called tumor-initiating cells or cancer stem-like cells,are known to be resistant to chemotherapy and radiotherapy,associated with tumor metastasis and recurrence after treatments,which attracts increasing attentions by developing advanced therapeutic methods in recent years.The possible therapeutic strategies that can eliminate CSCs generally include inhibiting their self-renewal pathway,differentiating CSCs,or targeting the CSCs niche.